Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

scientific article

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/TCRM.S33674
P932PMC publication ID3448455
P698PubMed publication ID23028230

P50authorPaolo BonfantiQ56334013
P2093author name stringGiuliano Rizzardini
Giorgio L Colombo
Sergio Di Matteo
Giovanna Orlando
Laura Carenzi
Massimo Coen
P2860cites workInsights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve PatientsQ38959219
Adherence to protease inhibitor therapy and outcomes in patients with HIV infectionQ39605935
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsQ40729054
The cost of HIV disease in Northern Italy: the payer's perspectiveQ43911880
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infectionQ44509935
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.Q44744113
Comparison of Markov model and discrete-event simulation techniques for HIV.Q46103481
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.Q46667493
The cost effectiveness of combination antiretroviral therapy for HIV disease.Q52067020
Providing antiretroviral therapy for HIV infectionQ73614013
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United StatesQ22242768
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Decline in the AIDS and death rates in the EuroSIDA study: an observational studyQ33967061
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in ItalyQ35205440
Cost-effectiveness analysis of initial HIV treatment under Italian guidelinesQ35602604
Changing health environment: the challenge to demonstrate cost-effectiveness of new compoundsQ36117463
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over timeQ36712393
Antiretroviral therapy and management of HIV infectionQ37770721
A review of mathematical models of HIV/AIDS interventions and their implications for policyQ37891590
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjectItalyQ38
P304page(s)377-384
P577publication date2012-09-17
P1433published inTherapeutics and Clinical Risk ManagementQ15766913
P1476titleCost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
P478volume8

Reverse relations

cites work (P2860)
Q26796419A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes
Q36956535Behavioral and clinical characteristics of people receiving medical care for HIV infection in an outpatient facility in Sicily, Italy
Q37412246Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
Q35111299Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
Q38759954Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective
Q37225380Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines